BOSTON – New research suggests that the protection offered by the Moderna vaccine against COVID-19 lasts at least six months.
The report Tuesday in the New England Journal of Medicine reflects what Pfizer said last week about the vaccine working in a similar way.
Both reports are based on follow-up tests in dozens of people who received the shots during studies that led to the use of the vaccines. These studies were done before new variants, or versions of the coronavirus, emerged and began to spread.
MESSENGER EXPECTED TO MAKE UP ADVANCE FOR ADULTS TO BE EQUIPPED FOR VACCINES
A separate report in the medical journal contributes to concerns about the variants. Scientists have measured antibodies that could block the virus in 50 people who received the vaccines Sinopharm or Sinovac developed in China. Many have shown complete or partial loss of efficacy against a virus variant first detected in South Africa.
CDC: THERE IS A 1 IN 1,000 CHANCE TO GET COVID-19 FROM SURFACES
The vaccines appear to be still protected against a variant first found in the UK and now rapidly spreading in the United States and elsewhere.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
Pfizer and Moderna said they are updating their vaccines, or possibly designing a booster shot, if needed at variants.